Evidence map›Paper›PMID 41271594›Full record

ReviewMacromolecular rapid communications2026

Advanced Macromolecular Architectures via Inorganic Polymers.

Edip Ajvazi, Pauline Stadler, Paul Strasser, Ian Teasdale

Abstract readReview
In one paragraph

Review in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advanced Macromolecular Architectures via Inorganic Polymers.Macromolecular rapid communications · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edip AjvaziInstitute of Polymer Chemistry, Johannes Kepler University, Linz, Austria.ORCID https://orcid.org/0000-0002-8475-5341
Pauline StadlerInstitute of Polymer Chemistry, Johannes Kepler University, Linz, Austria.ORCID https://orcid.org/0000-0002-9153-597X
Paul StrasserInstitute of Polymer Chemistry, Johannes Kepler University, Linz, Austria.ORCID https://orcid.org/0000-0001-9331-6570
Ian TeasdaleInstitute of Polymer Chemistry, Johannes Kepler University, Linz, Austria.ORCID https://orcid.org/0000-0001-5953-9084

Funding

Austrian Science Fund P 36208-NBL
6 · The paper itself

Abstract

Advanced macromolecular architectures, extending beyond mere chemical composition, are key to unlocking new functionalities in inorganic polymers. This review highlights recent advances in the design and synthesis of inorganic polymers with complex architectures, ranging from hyperbranched and graft polymers to dendrimers, such as hyperbranched polyphosphoester, star-branched polyphosphazenes and polydimethylsiloxane bottlebrushes, thus extending well beyond traditional linear chains. These structural motifs enable unique and tunable properties, such as degradation profiles and mechanical performance, expanding the range of applications in biomedical and technical fields. Particular emphasis is placed on synthetic strategies that enable precise architectural control. While such structural diversity is well established in organic systems, this review focuses on inorganic polymers featuring main-group elements in the polymer backbone and as key structural elements. Phosphorus- and silicon-based polymers, especially polyphosphazenes, polyphosphoesters, and polysiloxanes, constitute the majority of studied systems and are covered in depth, alongside emerging classes incorporating sulfur, tin, selenium, and metallocenes.

Indexed as

Inorganic ChemicalsMacromolecular SubstancesPolymersMolecular StructureInorganic ChemicalsMacromolecular SubstancesPolymersinorganic polymersmacromolecular architecturespolyphosphazenespolyphosphoesterspolysiloxanes

Identifiers

PMID41271594
PMCPMC12829527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.